Studyrowth in Vaccine R & D seen for the remainder of the decade.

Studyrowth in Vaccine R & D seen for the remainder of the decade, according to the Tufts Center for the Study Of Drug DevelopmentAlthough the number of anti-infective vaccines in the clinical study each year was on average higher than in 1990s, since 2000 years, recent trends can hardly be global growth in this range for the rest of of this decade, according to a recently completed study from the Tufts Center for the Study of Drug Development. ‘Despite widespread agreement that new vaccines are an important public health priority, the development is slow, expensive and risky,’said Tufts CSDD Director Kenneth I Kaitin.

Each year from 2000 to 2004 clinical trials for 14 products were launched, reports compared with an average of 12 per year from 1990 to 1999, according to findings in the July / August Tufts CSDD Impact Report, released today.May increase the use of estrogen treatment postmenopausal female, the risk of develop kidney stones, based on findings of the UT Southwestern Medical Center researchers. Sources: UT Southwestern Medical Center, AlphaGalileo Foundation.

Random entries

Other entries from category "hematology":